(Q42756908)

6 November 2017

0 references

1 reference

title

Limited joint mobility in diabetes and ageing: recent advances in pathogenesis and therapy (English)

1 reference

6 November 2017

M Abate

1

1 reference

6 November 2017

C Schiavone

series ordinal

2

1 reference

6 November 2017

P Pelotti

series ordinal

3

1 reference

6 November 2017

V Salini

series ordinal

4

1 reference

6 November 2017

publication date

1 October 2010

1 reference

International Journal of Immunopathology and Pharmacology

6 November 2017

published in

1 reference

6 November 2017

volume

23

1 reference

6 November 2017

issue

4

1 reference

6 November 2017

page(s)

997-1003

1 reference

The AGE of the matrix: chemistry, consequence and cure

6 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Differences in range of motion between dominant and nondominant sides of upper and lower extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Normal hip and knee active range of motion: the relationship to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Muscle performance and ankle joint mobility in long-term patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Advanced glycation end products: sparking the development of diabetic vascular injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Ageing of human muscles and tendons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Cross-linking in collagen and elastin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

An in vitro model to test the contribution of advanced glycation end products to bone biomechanical properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

The role of AGEs and AGE inhibitors in diabetic cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Serum endogenous secretory RAGE level is an independent risk factor for the progression of carotid atherosclerosis in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

Blockade of receptor for advanced glycation endproducts: a new target for therapeutic intervention in diabetic complications and inflammatory disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201002300404

10.1177/039463201002300404

21 January 2018

Identifiers

DOI

1 reference

6 November 2017

1 reference